Global Pathological Examination 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR092413480

Publication Date:

September 20, 2024

Pages:

119

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.
The global Pathological Examination market size was valued at US$ 32220 million in 2023 and is forecast to a readjusted size of USD 61430 million by 2030 with a CAGR of 9.8% during review period.
From perspective of type, pathological examination can be split into histopathology, cell pathology, immunohistochemical pathology and molecular pathology. In 2019, cell pathology took up for about 48% market share, which made it the largest segment of global pathological examination.
North America is the largest consumption region of pathological examination, with a consumption market share nearly 37% in 2019. The second place is Asia-Pacific; following North America with the consumption market share over 31% in 2020.
Key players of global pathological examination market are Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International. The top 5 players totally took up a market share of about 18% in 2019. Quest Diagnostics is in the first place, which accounted for above 5% of global market.
This report is a detailed and comprehensive analysis for global Pathological Examination market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Pathological Examination market size and forecasts, in consumption value ($ Million), 2019-2030
Global Pathological Examination market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Pathological Examination market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Pathological Examination market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pathological Examination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pathological Examination market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International, BML, Pathologists Diagnostic, StageBio, KingMed Diagnostics Group, Dian Diagnostics Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Pathological Examination market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Pathological Examination market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
麻豆原创 segment by Application
Hospital
Medical Laboratory
麻豆原创 segment by players, this report covers
Quest Diagnostics
Sonic Healthcare
Lab Corp
Unilabs
SYNLAB International
BML
Pathologists Diagnostic
StageBio
KingMed Diagnostics Group
Dian Diagnostics Group
Adicon Clinical Laboratories Inc.
Huayin Health
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pathological Examination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pathological Examination, with revenue, gross margin, and global market share of Pathological Examination from 2019 to 2024.
Chapter 3, the Pathological Examination competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pathological Examination market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pathological Examination.
Chapter 13, to describe Pathological Examination research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Pathological Examination by Type
1.3.1 Overview: Global Pathological Examination 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pathological Examination Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Histopathology
1.3.4 Cytopathology
1.3.5 Immunohistochemical Pathology
1.3.6 Molecular Pathology
1.4 Global Pathological Examination 麻豆原创 by Application
1.4.1 Overview: Global Pathological Examination 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Medical Laboratory
1.5 Global Pathological Examination 麻豆原创 Size & Forecast
1.6 Global Pathological Examination 麻豆原创 Size and Forecast by Region
1.6.1 Global Pathological Examination 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pathological Examination 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Pathological Examination 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Pathological Examination 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pathological Examination 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Pathological Examination 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Pathological Examination 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business
2.1.3 Quest Diagnostics Pathological Examination Product and Solutions
2.1.4 Quest Diagnostics Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Quest Diagnostics Recent Developments and Future Plans
2.2 Sonic Healthcare
2.2.1 Sonic Healthcare Details
2.2.2 Sonic Healthcare Major Business
2.2.3 Sonic Healthcare Pathological Examination Product and Solutions
2.2.4 Sonic Healthcare Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Sonic Healthcare Recent Developments and Future Plans
2.3 Lab Corp
2.3.1 Lab Corp Details
2.3.2 Lab Corp Major Business
2.3.3 Lab Corp Pathological Examination Product and Solutions
2.3.4 Lab Corp Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Lab Corp Recent Developments and Future Plans
2.4 Unilabs
2.4.1 Unilabs Details
2.4.2 Unilabs Major Business
2.4.3 Unilabs Pathological Examination Product and Solutions
2.4.4 Unilabs Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Unilabs Recent Developments and Future Plans
2.5 SYNLAB International
2.5.1 SYNLAB International Details
2.5.2 SYNLAB International Major Business
2.5.3 SYNLAB International Pathological Examination Product and Solutions
2.5.4 SYNLAB International Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 SYNLAB International Recent Developments and Future Plans
2.6 BML
2.6.1 BML Details
2.6.2 BML Major Business
2.6.3 BML Pathological Examination Product and Solutions
2.6.4 BML Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 BML Recent Developments and Future Plans
2.7 Pathologists Diagnostic
2.7.1 Pathologists Diagnostic Details
2.7.2 Pathologists Diagnostic Major Business
2.7.3 Pathologists Diagnostic Pathological Examination Product and Solutions
2.7.4 Pathologists Diagnostic Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Pathologists Diagnostic Recent Developments and Future Plans
2.8 StageBio
2.8.1 StageBio Details
2.8.2 StageBio Major Business
2.8.3 StageBio Pathological Examination Product and Solutions
2.8.4 StageBio Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 StageBio Recent Developments and Future Plans
2.9 KingMed Diagnostics Group
2.9.1 KingMed Diagnostics Group Details
2.9.2 KingMed Diagnostics Group Major Business
2.9.3 KingMed Diagnostics Group Pathological Examination Product and Solutions
2.9.4 KingMed Diagnostics Group Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 KingMed Diagnostics Group Recent Developments and Future Plans
2.10 Dian Diagnostics Group
2.10.1 Dian Diagnostics Group Details
2.10.2 Dian Diagnostics Group Major Business
2.10.3 Dian Diagnostics Group Pathological Examination Product and Solutions
2.10.4 Dian Diagnostics Group Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Dian Diagnostics Group Recent Developments and Future Plans
2.11 Adicon Clinical Laboratories Inc.
2.11.1 Adicon Clinical Laboratories Inc. Details
2.11.2 Adicon Clinical Laboratories Inc. Major Business
2.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Product and Solutions
2.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Adicon Clinical Laboratories Inc. Recent Developments and Future Plans
2.12 Huayin Health
2.12.1 Huayin Health Details
2.12.2 Huayin Health Major Business
2.12.3 Huayin Health Pathological Examination Product and Solutions
2.12.4 Huayin Health Pathological Examination Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Huayin Health Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Pathological Examination Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Pathological Examination by Company Revenue
3.2.2 Top 3 Pathological Examination Players 麻豆原创 Share in 2023
3.2.3 Top 6 Pathological Examination Players 麻豆原创 Share in 2023
3.3 Pathological Examination 麻豆原创: Overall Company Footprint Analysis
3.3.1 Pathological Examination 麻豆原创: Region Footprint
3.3.2 Pathological Examination 麻豆原创: Company Product Type Footprint
3.3.3 Pathological Examination 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Pathological Examination Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Pathological Examination 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Pathological Examination Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Pathological Examination 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Pathological Examination Consumption Value by Type (2019-2030)
6.2 North America Pathological Examination 麻豆原创 Size by Application (2019-2030)
6.3 North America Pathological Examination 麻豆原创 Size by Country
6.3.1 North America Pathological Examination Consumption Value by Country (2019-2030)
6.3.2 United States Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Pathological Examination Consumption Value by Type (2019-2030)
7.2 Europe Pathological Examination Consumption Value by Application (2019-2030)
7.3 Europe Pathological Examination 麻豆原创 Size by Country
7.3.1 Europe Pathological Examination Consumption Value by Country (2019-2030)
7.3.2 Germany Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Pathological Examination Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pathological Examination Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pathological Examination 麻豆原创 Size by Region
8.3.1 Asia-Pacific Pathological Examination Consumption Value by Region (2019-2030)
8.3.2 China Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Pathological Examination Consumption Value by Type (2019-2030)
9.2 South America Pathological Examination Consumption Value by Application (2019-2030)
9.3 South America Pathological Examination 麻豆原创 Size by Country
9.3.1 South America Pathological Examination Consumption Value by Country (2019-2030)
9.3.2 Brazil Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Pathological Examination Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pathological Examination Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pathological Examination 麻豆原创 Size by Country
10.3.1 Middle East & Africa Pathological Examination Consumption Value by Country (2019-2030)
10.3.2 Turkey Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Pathological Examination 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Pathological Examination 麻豆原创 Drivers
11.2 Pathological Examination 麻豆原创 Restraints
11.3 Pathological Examination Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pathological Examination Industry Chain
12.2 Pathological Examination Upstream Analysis
12.3 Pathological Examination Midstream Analysis
12.4 Pathological Examination Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.